Arkolith/Insider Trading/AXSM/Form 4

Tabuteau Herriot

Chief Executive Officer, Director, 10% OwnerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Nov 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21.8M
Net Open-Market Flow
-$21.8M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 5, 2025Sell(S)22K$134.49$2.9M7K
Nov 5, 2025Option exercise(M)22K$8.02$175K29K
Nov 4, 2025Sell(S)50K$133.79$6.8M7K
Nov 4, 2025Option exercise(M)50K$8.02$405K58K
Nov 3, 2025Sell(S)92K$132.34$12.1M7K
Nov 3, 2025Option exercise(M)92K$8.02$735K99K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 5, 2025Option exercise(M)22K—$0252K
Nov 4, 2025Option exercise(M)50K—$0274K
Nov 3, 2025Option exercise(M)92K—$0324K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-267467) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML